Back to top
more

Cardiovascular Systems, Inc. (CSII)

(Delayed Data from NSDQ)

$39.49 USD

39.49
435,746

+1.98 (5.28%)

Updated May 3, 2019 04:00 PM ET

After-Market: $39.52 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates

Hill-Rom Holdings, Inc. (HRC) reported first-quarter fiscal 2017 adjusted earnings per share of 75 cents, up 10.3% from the year-ago quarter.

    Cardiovascular Systems (CSII) Q2 Earnings Better Estimates

    Cardiovascular Systems, (CSII) reported earnings per share of 3 cents in second-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's loss of 47 cents.

      Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17

      Mead Johnson (MJN) reported fourth-quarter 2016 adjusted EPS of 78 cents, missing the Zacks Consensus Estimate of 83 cents by 6%.

        Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View

        Quest Diagnostics' (DGX) fourth-quarter 2016 adjusted earnings per share (EPS) of $1.31 came in 4 cents ahead of the Zacks Consensus Estimate.

          PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues

          PetMed Express (PETS) announced earnings per share (EPS) of 24 cents for the third quarter of fiscal 2017.

            Tirthankar Chakraborty headshot

            New Strong Buy Stocks for January 26th

            Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

              Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line

              Abbott Laboratories (ABT) reported fourth-quarter 2016 earnings from continuing operations of 65 cents per share, a penny higher than the Zacks Consensus Estimate.

                ResMed (RMD) Beats Earnings and Revenue Estimates in Q2

                ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.

                  Medical Product Stock Earnings on Jan 25: MCK, VAR & More

                  Let's take a look at the major Medical Product stocks slated to release their earnings results on Jan 25.

                    Tirthankar Chakraborty headshot

                    New Strong Buy Stocks for January 23rd

                    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

                      Quest Diagnostics (DGX) Launches HBV Quantitative Test

                      Quest Diagnostics Inc. (DGX), a global provider of diagnostic information services, recently rolled out Hepatitis B Virus (HBV) Quantitative Test.

                        VWR Buys SEASTAR CHEMICALS to Boost Americas Division

                        VWR Corporation (VWR) recently announced the acquisition of Canada-based SEASTAR CHEMICALS Inc.

                          Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger

                          On Dec 27, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

                            4 Growth Stocks to Buy Amid Obamacare Repeal Talks

                            Affordable Care Act (ACA) has been one of the most discussed topics during the 2016 U.S. presidential election. Even after a month, it has been contributing to the discord in the healthcare investment market.

                              Omnicell Unveils XT Series Automated Dispensing System

                              Omnicell, Inc. (OMCL) recently introduced a new generation of medication and supply automation that is fully integrated with the company's Unity enterprise platform -- XT series.

                                Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical

                                Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical

                                  Kevin Matras headshot

                                  Top Stocks with Big Potential Catch-Up Moves

                                  Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include CSCO, CSII, FIVN, GNRC and NXTM.

                                    Tirthankar Chakraborty headshot

                                    New Strong Buy Stocks for November 4th

                                    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday